Statement Of Cash Flows [Abstract]

Zealand Pharma - Filing #5889383

Concept 2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Increase (decrease) in working capital
122,379,000 DKK
52,103,000 DKK
Income taxes refund, classified as operating activities
11,155,000 DKK
11,300,000 DKK
Finance costs paid, classified as operating activities
24,031,000 DKK
25,252,000 DKK
Finance income received, classified as operating activities
119,010,000 DKK
37,887,000 DKK
Cash flows from (used in) investing activities [abstract]
Purchase of financial instruments, classified as investing activities
11,457,664,000 DKK
2,159,831,000 DKK
Proceeds from sales or maturity of financial instruments, classified as investing activities
4,137,897,000 DKK
1,089,547,000 DKK
Cash flows from (used in) financing activities [abstract]
Proceeds from exercise of warrants
30,727,000 DKK
63,950,000 DKK
Payments for share issue costs
236,579,000 DKK
71,908,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.